One question, in light of FREEDOM, is how well new DES compare with CABG in patients with diabetes and multivessel disease.

Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, will release its financial results ...

In patients with unprotected left main stenosis, there was no difference in all-cause mortality at 10 years between patients who had percutaneous coronary intervention and those who underwent coronary ...

Taylor Swift's dad treated the hospital like it was The Eras Tour after undergoing quintuple bypass surgery earlier this summer. In her debut appearance on the "New Heights" podcast on Aug. 13, Taylor ...